Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
<b>Background/Objectives</b>: Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases, characterized by an articular and extra-articular involvement, where autoantibodies, such as rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibodies (ACPAs), are impo...
Saved in:
Main Authors: | Juan Irure-Ventura, María Díaz-Toledo, Noelia Palazuelos-Cayón, Marcos López-Hoyos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/15/2/135 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A study of serum YKL-40 and its correlation with traditional biomarkers in rheumatoid arthritis patients
by: Vinod Narayan, et al.
Published: (2019-01-01) -
Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
by: Gokhan Sargin, et al.
Published: (2018-01-01) -
Prognostic importance of human leukocyte antigen DRβ1 gene and protein tyrosine phosphatase nonreceptor Type 22 gene polymorphism in rheumatoid arthritis
by: Pramod Kumar Verma, et al.
Published: (2017-01-01) -
Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
by: Lakshmi Deepika Yarlagadda, et al.
Published: (2020-01-01) -
High-Titer Rheumatoid Factor is Associated with Worse Clinical Outcomes and Higher Needs for Advanced Therapies in Rheumatoid Arthritis Under Real-Life Conditions
by: Victor Davi R. S. Oliveira, et al.
Published: (2024-12-01)